Other
Muscle Cramp
24
Pipeline Programs↗
1
Active Trials↗
16
Companies Involved↗
Muscle Cramp is an emerging landscape with 24 programs across 16 companies. The most active players are Vitae Pharmaceuticals Inc., an Allergan affiliate, Revance Therapeutics, Inc., Otsuka. 13 therapies are approved with 8 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical1
Phase 21
Phase 38
Analysis
Trial Status
12
clinical trials
Unknown status5 · 42%
Completed5 · 42%
Recruiting1 · 8%
Terminated1 · 8%
Clinical Trials
Trial Activity
12 trials
Study of Orphenadrine' in the Treatment of Muscle Cramps in Patients With Cirrhosis
Recruiting·—·Phase 3·NCT02423395·100 enrolled
Mexiletine for the Treatment of Muscle Cramps in ALS
Completed·—·Phase 4·NCT01811355·23 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)